Kidney Care & Dialysis Systems
Medserv Africa is a licensed specialty pharmaceutical and medical device distributor bridging the critical supply gap for nephrology suites, hospital hemodialysis centers, ICU critical care units, and home dialysis patients. From high-flux biocompatible dialyzers and ultrapure fluids to cold-chain erythropoietin and 24/7 acute emergency replenishment.
Closing the Renal Care Equity Gap in East Africa
Chronic Kidney Disease (CKD) has emerged as one of the most pressing non-communicable disease challenges across Sub-Saharan Africa. Fueled by rising prevalence of hypertension, type 2 diabetes mellitus, chronic glomerulonephritis, and late-stage presentation, an estimated 10% to 14% of adults in East Africa live with impaired renal function.
Historically, patients requiring maintenance hemodialysis suffered from critical supply bottlenecks—reusable dialyzer degradation, pyrogen reactions, dialysate stockouts, and unpredictable cold-chain failures for erythropoietin.
Medserv's Operational Mandate: We eliminate supply unpredictability through licensed, direct-to-hospital consignment agreements, Pharmacy and Poisons Board (PPB) registered products, and validated cold-chain corridors (2°C – 8°C) ensuring zero interrupted sessions.
Whether outfitting a new 20-station hospital dialysis center in Nairobi or supplying emergency CRRT cassettes to an ICU in Kisumu or Mombasa, Medserv Africa guarantees institutional-grade reliability.
More than 10% of the world's population lives with kidney disease, with disproportionate morbidity in developing healthcare systems.
Average CKD prevalence across Kenya and East Africa, often diagnosed late at Stage 4 or Stage 5 due to silent early symptoms.
Continuous digital IoT data logger monitoring for all erythropoietin (ESA) and biologic shipments from central cold store to clinic.
Dedicated renal and acute CRRT emergency dispatch line ensuring immediate delivery for urgent hospital cases.
The Complete Renal Replacement Spectrum
No single dialysis modality fits every clinical profile. Explore Medserv's distribution capabilities across in-center hemodialysis, home peritoneal dialysis, acute intensive care CRRT, and post-transplant care.
High-Flux Biocompatible Hemodialysis & Online HDF
In-center hemodialysis remains the clinical backbone of maintenance renal replacement therapy across East Africa. Medserv Africa supplies hospital dialysis units and private renal centers with industry-leading high-flux polysulfone and Helixone® membrane dialyzers, designed to maximize middle-molecule uremic toxin clearance (β2-microglobulin) while strictly preventing albumin loss.
Through our partnership network, we deliver complete operational packages: dry bicarbonate powder cartridges (bibag®) that eliminate bacterial bio-contamination inherent to liquid tanks, pyrogen-free bloodline tubing sets, and precision ultra-pure endotoxin filters (Diasafe® plus).
Polysulfone & Helixone membranes (1.4m² to 2.2m²), steam sterilized with zero residual ethylene oxide risk.
Solid powder dry bicarbonate cartridges ensuring aseptic, on-demand bicarbonate mixing at bedside.
Ultra-thin wall 15G, 16G, and 17G AV fistula needles with back-eye slots and needle-stick safety locks.
Citric acid 50% thermal disinfectant, peracetic acid, antiscalants, and microbial water test kits.
Empowering Patient Freedom: Peritoneal Dialysis & Home HD
Home dialysis offers patients unparalleled freedom, preserving residual kidney function (RRF), improving hemodynamic stability, and removing the burden of traveling to hospital dialysis suites 3 times a week. Medserv Africa provides full distribution and cold-chain logistics for both Peritoneal Dialysis (PD) and Home Hemodialysis (HHD).
Our PD portfolio includes Automated Peritoneal Dialysis (APD) overnight cyclers (sleep•safe harmony) that perform fluid exchanges quietly while the patient sleeps, as well as Continuous Ambulatory Peritoneal Dialysis (CAPD) stay•safe twin-bag disconnect systems equipped with patented PIN technology to minimize peritonitis risks.
Automated cyclers with personalized fluid profiling and digital memory cards for clinical compliance tracking.
Closed-system disconnect technology with automatic disc flushing to dramatically reduce touch peritonitis.
Non-glucose iso-osmolar PD fluid for long day dwells, ideal for diabetic patients and high transporters.
Scheduled doorstep delivery of heavy dialysate boxes directly into patient residences across Kenyan counties.
Continuous Renal Replacement Therapy (CRRT) for ICU
Critically ill patients in Intensive Care Units (ICUs) suffering from septic shock, multiorgan failure, or acute hemodynamic collapse cannot tolerate standard high-speed 4-hour hemodialysis. Continuous Renal Replacement Therapy (CRRT) provides gentle, 24-hour continuous solute clearance and fluid balance.
Medserv Africa distributes acute continuous therapies modeled on the multiFiltratePRO platform. We maintain dedicated hospital stocks of sterile pre-connected cassettes for CVVH (Continuous Veno-Venous Hemofiltration), CVVHD, and CVVHDF, together with physiological bicarbonate replacement fluids and regional citrate anticoagulation (Ci-Ca) solutions.
Pre-connected tubing and Ultraflux® AV hemofilter cassettes for rapid ICU setup with zero line-crossing errors.
Targeted regional circuit anticoagulation dramatically extending filter life without systemic patient bleeding risks.
MultiBic and multiPlus physiological balanced calcium and bicarbonate substitution bags.
24/7 emergency dispatch service for urgent acute hemofiltration cassettes to ICU wards in Nairobi and regional hospitals.
Transplantation Bridge & Immunosuppressive Continuity
Kidney transplantation represents the definitive gold-standard therapy for suitable ESRD patients, offering restored renal function and long-term quality of life. Medserv Africa plays a pivotal role in the transplant continuum across Kenya: optimizing dialysis adequacy (Kt/V) and nutrition while patients are on the waiting list, and ensuring seamless cold-chain delivery of post-transplant immunosuppressives.
We distribute essential post-graft maintenance pharmaceuticals under strict temperature verification, preventing catastrophic allograft rejection episodes and supporting regional transplant centers in Nairobi, Eldoret, and regional hospitals.
Tacrolimus (Prograf®, Advagraf® once-daily) and Cyclosporine microemulsion capsules.
Mycophenolate Mofetil (CellCept®) and enteric-coated Mycophenolate Sodium (Myfortic®).
Everolimus (Certican®) for CNI-sparing protocols, plus oral Methylprednisolone.
Valganciclovir (Valcyte®) for CMV prevention, co-trimoxazole, and antifungal prophylactic regimens.
Navigating Chronic Kidney Disease: Stages 1 to 5
Empowering clinicians, patients, and families with clarity at every phase. Structured stage-by-stage clinical pathways guiding early detection, disease deceleration, vascular access preparation, and maintenance renal replacement.
Stage 1: Normal Filtration with Evidence of Kidney Damage
In Stage 1, kidneys still filter waste efficiently (eGFR ≥ 90 mL/min), but laboratory findings reveal physical kidney damage—typically demonstrated by persistent microalbuminuria (urine albumin-to-creatinine ratio ≥ 30 mg/g) or structural anomalies on renal ultrasound.
- Primary Goal: Identify root etiologies (hypertension, diabetes mellitus, glomerulonephritis) and implement aggressive nephroprotection.
- Target Blood Pressure: < 130/80 mmHg using ACE inhibitors or Angiotensin Receptor Blockers (ARBs) to decrease intraglomerular pressure.
- Lifestyle & Nutrition: Sodium restriction (< 2g/day), smoking cessation, weight management, and avoiding nephrotoxic NSAIDs.
Distribution of microalbuminuria diagnostic strips, blood pressure monitoring devices, and guideline-recommended ACEi/ARBs to outpatient hospital pharmacies.
Pharmacy Outpatient Formularies >Stage 2: Mild Filtration Decline with Proteinuria
eGFR drops slightly to 60–89 mL/min accompanied by ongoing kidney damage. Most patients remain asymptomatic, making routine annual blood creatinine and urine protein checks critical to prevent silent functional decline.
- Primary Goal: Decelerate the annual eGFR decline slope and prevent cardiovascular co-morbidities.
- Therapeutic Intervention: SGLT2 inhibitors (Dapagliflozin, Empagliflozin) demonstrated to preserve renal parenchyma and reduce CKD progression by up to 39%.
- Lipid Management: Statins for cardiovascular risk reduction; strict glycemic control (HbA1c < 7.0%).
Guaranteed cold-chain and ambient distribution of licensed SGLT2 inhibitors and guideline-recommended cardioprotective regimens across East Africa.
Explore Cardioprotective Distribution >Stage 3: Moderate CKD (Substages 3a: 45–59 & 3b: 30–44 mL/min)
Kidneys have lost half their functional capacity. Waste products, urea, and electrolytes begin accumulating. Patients frequently experience fatigue, fluid retention (edema in feet and ankles), nocturnal urination, and early secondary anemia.
- Anemia Management: Screening ferritin, transferrin saturation (TSAT), and hemoglobin. Initiation of intravenous or oral iron therapy and erythropoiesis-stimulating agents (ESAs) if Hb < 10 g/dL.
- Mineral & Bone Disorder (CKD-MBD): Managing elevated serum phosphorus and parathyroid hormone (PTH); calcitriol supplementation.
- Metabolic Acidosis: Sodium bicarbonate supplementation when serum bicarbonate < 22 mmol/L to protect muscle mass and bone density.
Cold-chain (2°C – 8°C) distribution of Epoetin alfa/beta, intravenous iron sucrose (Venofer-equivalent), calcium-free phosphate binders, and oral bicarbonate.
View Renal Anemia Products >Stage 4: Severe Impairment & Active Dialysis Preparation
eGFR is between 15 and 29 mL/min. Kidneys are approaching failure. Clinicians must actively prepare the patient for Renal Replacement Therapy (RRT) before uremic emergency forces unplanned catheter insertion.
- Modality Education: Comprehensive counseling on In-Center Hemodialysis vs. Home Peritoneal Dialysis vs. Preemptive Living Donor Kidney Transplant.
- Vascular Access Planning: Surgical creation of an Arteriovenous (AV) Fistula in the non-dominant arm minimum 3–6 months prior to anticipated dialysis, allowing vein arterialization.
- Peritoneal Catheter Insertion: Laparoscopic Tenckhoff catheter placement if the patient selects home peritoneal dialysis.
- Transplant Workup: Initiating immunological cross-matching, tissue typing, and prospective donor screening.
Supply of surgical AV access graft materials, temporary dual-lumen hemodialysis catheters, Tenckhoff PD catheter kits, and patient pre-dialysis education packs.
Vascular Access Consumables >Stage 5: End-Stage Renal Disease (ESRD) & Kidney Failure
eGFR is below 15 mL/min. Kidneys can no longer sustain life independently. Advanced uremia presents with severe nausea, pruritus, pericardial friction rub, pulmonary edema, hyperkalemia, and profound lethargy.
- Initiation of RRT: Maintenance hemodialysis (typically 3 sessions/week, 4 hours each) or daily peritoneal dialysis exchanges (APD/CAPD).
- Dry Weight Management: Regular ultrafiltration titration to achieve true normovolemia without intradialytic hypotension or muscle cramping.
- Dialysis Adequacy: Ensuring monthly single-pool Kt/V ≥ 1.4 for hemodialysis or weekly Kt/V ≥ 1.7 for peritoneal dialysis.
- Transplantation: Active listing on regional transplant registry or proceeding with scheduled live donor surgery.
Consignment of high-flux dialyzers, bloodlines, bibags, stay•safe PD bags, 2°C – 8°C ESAs, phosphate binders, and emergency ICU CRRT kits across East Africa.
Explore Maintenance Dialysis Sourcing >Specialized Renal Equipment & Urology Formulary
Medserv Africa is a licensed specialty distributor regulated by the Pharmacy and Poisons Board of Kenya (PPB). Sourced directly from accredited global manufacturers and distributed under strict WHO Good Distribution Practice (GDP).
These high-end medical supplies are used alongside dialysis, continuous renal replacement therapy (CRRT), and intensive care blood-filtering systems:
Tubing Set for Blood Purification (Heparin Coated)
Specialized extracorporeal circuit tubing set designed for advanced blood purification and hemodialysis procedures, utilizing heparin anticoagulation to prevent clotting during renal therapy.
Cytokine-Adsorption Cartridge Connection Adapter (Universal)
Universal connection adapter utilized to seamlessly integrate cytokine-adsorption blood purification cartridges into standard hemodialysis and continuous renal replacement therapy (CRRT) machines.
Intensive Care Renal Support Cartridge Bridge Adapter
Secondary configuration adapter designed to safely bridge advanced cytokine-adsorption cartridges with standard intensive care renal support systems.
Double-Filtration Apheresis (DFPP) Tubing Circuit
Premium double-filtration apheresis tubing circuit used in therapeutic plasma exchange to filter out high-molecular-weight proteins and pathogenic antibodies, preventing autoimmune-related renal damage.
These medications treat structural urinary conditions, aid in the expulsion of kidney stones, and treat severe infections that threaten upper urinary tract and kidney function:
| Generic Active Molecule & Strength | Dosage Form | Clinical Indication & Renal Impact |
|---|---|---|
| Dutasteride 0.5mg / Tamsulosin 0.4mg | Modified-Release Capsules | Dual-action combination therapy designed to relax urinary tract smooth muscle and reduce urinary retention, preventing back-pressure damage to the kidneys. |
| Finasteride 5mg | Film-Coated Tablets | 5-alpha reductase inhibitor indicated for reducing urinary tract obstruction and improving overall urine flow. |
| Finasteride 5mg / Tamsulosin 400mcg | Fixed-Dose Tablets | Fixed-dose combination medication formulated to ease urinary flow blockages and reduce severe bladder resistance. |
| Finasteride / Tamsulosin (Combination) | Oral Capsules | Combination formula utilized to treat lower urinary tract symptoms, lower post-void residual volume, and protect the upper renal system. |
| Fosfomycin Trometamol 3gm | Oral Granules (Sachet) | Single-dose, broad-spectrum antibiotic indicated for acute lower urinary tract infections to prevent ascending progression to acute kidney infections (pyelonephritis). |
| Fosfomycin 3gm (Rapid-Acting) | Oral Solution Sachet | Rapid-acting antibacterial oral solution designed to eliminate complicated and uncomplicated urinary tract infections. |
| Oxybutynin Hydrochloride 2.5mg | Scored Tablets | Anticholinergic medication used to treat neurogenic bladder and overactive bladder spasms, mitigating the risk of hydronephrosis (kidney swelling). |
| Oxybutynin Hydrochloride 5mg | Oral Tablets | Higher strength urinary antispasmodic indicated for severe bladder instability and the prevention of high-pressure vesicoureteral reflux. |
| Oxybutynin 5mg (Detrusor Relaxant) | Film-Coated Tablets | Bladder relaxant formulated to control bladder urgency, frequency, and related urinary tract discomfort. |
| Pentosan Polysulfate Sodium | Oral Capsules | Low-molecular-weight heparinoid indicated for the relief of bladder pain and discomfort associated with interstitial cystitis. |
| Tamsulosin 400mcg + Finasteride 5mg | Bilayer Tablets | Combined alpha-blocker and 5-alpha reductase inhibitor to relieve critical urinary retention and aid the passage of large nephroliths (kidney stones). |
| Tamsulosin 400mcg + Finasteride 5mg (Synergy) | Oral Tablets | Synergy medication targeted at improving urological output and stabilizing outflow paths. |
| Tamsulosin 400mcg + Tadalafil 5mg | Combination Tablets | Specialized urological formula designed to relax the smooth muscle tissues of the bladder neck and lower urinary system to ease voiding. |
| Standardized Urological Bioactive Complex 25mg | Softgel Capsules | Specialized softgel formulation supporting urological smooth muscle tone and pelvic microvascular compliance. |
| Sildenafil Citrate 50mg | Film-Coated Tablets | Selective PDE-5 inhibitor indicated for lower urinary tract perfusion and endothelial vascular smooth muscle relaxation. |
For hospital consignment agreements, theatre emergency supply, or named-patient importation, contact the Medserv Clinical Supply Desk at +254 719 759 804 or email info@medserv.africa.
Clinical Nephrology Education & Nursing Quality Support
High-quality clinical outcomes require skilled practitioners. In collaboration with global educators, Medserv Africa provides dialysis nurses, clinical officers, and biomedical technicians with evidence-based training resources and accredited protocols.
Water Purity & AAMI / ISO 23500
Guidelines and standard operating procedures for reverse osmosis (RO) maintenance, pyrogen testing, endotoxin threshold validation (< 0.25 EU/mL), and chemical water purification to prevent severe intradialytic chills and pyrogenic reactions.
Explore Water Validation Standards >AV Fistula Cannulation & Access Care
Best-practice vascular access preservation modules: comparing the Rope-Ladder technique vs. the Buttonhole method, blunt safety needles, aneurysmal dilatation prevention, and early ultrasound surveillance of vascular stenosis.
Vascular Access & PTA Consumables >Kt/V Dialysis Adequacy Optimization
Clinical protocols on blood flow rate (Qb) titration, effective dialysate flow (Qd), urea reduction ratio (URR) calculations, and middle-molecule convective clearance using modern Online Hemodiafiltration (HighVolumeHDF).
Health Economics & Adequacy Outcomes >Empowering Patients and Care Partners
A diagnosis of chronic kidney disease or kidney failure can feel overwhelming. Medserv Africa believes that with evidence-based clinician support, proper dietary guidance, family education, and dependable supply of modern dialysis consumables, individuals living with kidney disease can continue living active, vibrant, and fulfilling lives.
Explore our patient empowerment toolkits—designed specifically for Kenyan families navigating the emotional, physical, and nutritional aspects of renal care:
Read Our Patient Impact Stories >Common Clinical & Distribution Inquiries
Answers to key operational, regulatory, and clinical questions regarding our renal distribution services across East Africa.
Regulatory Notice: Medserv Africa is a licensed specialty pharmaceutical and medical device distributor regulated by the Pharmacy and Poisons Board of Kenya (PPB) adhering to World Health Organization Good Distribution Practice (WHO-GDP). Medserv Africa does not manufacture medical devices or pharmaceuticals; all dialysis systems, filtration products, and renal medications are sourced directly from accredited global innovators and licensed multinational manufacturing partners. The clinical information provided on this page is intended exclusively for registered medical practitioners, nephrologists, renal nurses, and healthcare institutions. For product-specific indications, contraindications, and prescribing guidelines, consult the manufacturer's Summary of Product Characteristics (SmPC).